Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Mortality in South Asians and Caucasians After Percutaneous Coronary Intervention in the United Kingdom. An Observational Cohort Study of 279,256 Patients From the BCIS (British Cardiovascular Intervention Society) National Database

Daniel A. Jones, MD∗; Sean Gallagher, MD∗; Krishnaraj S. Rathod, MD∗; Simon Redwood, MD‡; Mark A. de Belder, MD§; Anthony Mathur, MD, PhD∗; Adam D. Timmis, MD∗; Peter F. Ludman, MD‖; John N. Townend, MD‖; Andrew Wragg, MD, PhD∗

Objectives: The purpose of this study was to compare baseline characteristics and medium-term prognosis in South Asian and Caucasian patients undergoing percutaneous coronary intervention (PCI).

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Impact of Cigarette Smoking on Extent of Coronary Artery Disease and Prognosis of Patients With Non–ST-Segment Elevation Acute Coronary Syndromes. An Analysis From the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy)

Jason O. Robertson, MD, MS∗; Ramin Ebrahimi, MD†; Alexandra J. Lansky, MD‡; Roxana Mehran, MD§; Gregg W. Stone, MD‖; A. Michael Lincoff, MD∗

Objectives: This study sought to evaluate the short- and long-term outcomes for smokers with non–ST-segment elevation acute coronary syndromes (NSTE-ACS).

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. MitraClip Therapy in Surgical High-Risk Patients. Identification of Echocardiographic Variables Affecting Acute Procedural Outcome

Edith Lubos, MD∗; Michael Schlüter, PhD∗; Eik Vettorazzi, MSc†; Britta Goldmann, MD∗; Daniel Lubs, MD∗; Johannes Schirmer, MD‡; Hendrik Treede, MD‡; Hermann Reichenspurner, MD, PhD‡; Stefan Blankenberg, MD∗; Stephan Baldus, MD∗; Volker Rudolph, MD∗

Objectives: The aim of the study was to assess predictors of acute procedural failure in surgical high-risk patients undergoing MitraClip (Abbott Vascular, Abbott Park, Illinois) therapy.

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Effect of Catheter-Based Patent Foramen Ovale Closure on the Occurrence of Arterial Bubbles in Scuba Divers

Jakub Honěk, MD∗; Martin Šrámek, MD†; Luděk Šefc, PhD†; Jaroslav Januška, MD§; Jiří Fiedler, MD∗; Martin Horváth, MD∗; Aleš Tomek, MD‡; Štěpán Novotný, MD‖; Tomáš Honěk, MD, PhD∗; Josef Veselka, MD, PhD∗

Objectives: This study sought to evaluate the effect of catheter-based patent foramen ovale (PFO) closure on the occurrence of arterial bubbles after simulated dives.

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. The PFO Gets Blamed Again…Perhaps This Time it Is Real

Alfred A. Bove, MD, PhD

Patent foramen ovale (PFO) closure is the thing to do these days in the interventional laboratory. Closures are done for strokes, migraine headaches, and postural cyanosis, and for divers who are at risk for decompression sickness. Atrial septal defect closures are also done in the interventional laboratory, but these are known to reduce the significant left-to-right intracardiac shunt that eventually, when large enough, results in pulmonary hypertension, an Eisenmenger syndrome, and permanent lung injury.

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Comparison Between Covered and Bare Cheatham-Platinum Stents for Endovascular Treatment of Patients With Native Post-Ductal Aortic Coarctation. Immediate and Intermediate-Term Results

Bahram Sohrabi, MD∗; Peiman Jamshidi, MD∗; Alireza Yaghoubi, MD∗; Afshin Habibzadeh, MD∗; Yashar Hashemi-aghdam, MD‡; Araz Moin, MD‡; Babak Kazemi, MD∗; Samad Ghaffari, MD∗; Mohammad Reza Abdolahzadeh Baghayi, MD∗; Khalil Mahmoody, MD§

Objectives: This study sought to evaluate the outcomes of endovascular treatment with covered versus bare Cheatham-platinum stents (NuMed, Hopkinton, New York) in coarctation of aorta (CoA) patients.

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Covered Stents for Coarctation of the Aorta. Treating the Interventionalist or the Patient?

Ziyad M. Hijazi, MD, MPH; Damien P. Kenny, MB, MD

Interventionalists treating congenital heart lesions are constantly faced with challenging therapeutic decisions, often without randomized trials to support one approach over the other. Indeed, detailed outcome data, particularly outside of the United States, may lag behind the availability of a particular device or stent, and therefore, application of a procedure may be based on rational thought and evolving clinical experience rather than on published trials. This is certainly the case with the use of covered stents for endovascular treatment of coarctation of the aorta (CoA). Therapeutic options for native CoA in adults have evolved from surgical correction through balloon angioplasty in the early 1980s to stent implantation in the 1990s. Concerns regarding the potential for aortic wall trauma with endovascular arterioplasty evolved following reports describing high aneurysm rates (7% to 20%)

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Successful Transcatheter Aortic Valve Replacement in a Patient With a Sinus of Valsalva Aneurysm

Cara Hendry, MBChB, MD; Anthony Della Siega, MD; Imad J. Nadra, MBChB, BSc, PhD; Simon D. Robinson, MBChB, BSc, MD

Transcatheter aortic valve replacement (TAVR) is increasingly being used to treat patients with severe aortic stenosis who are either deemed to be inoperable or at prohibitive surgical risk. Both operator experience and devices have evolved over time, as have the indications for valve implantation.

01 abril 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Self-Expanding Stent Peeling Away From Overlapping Balloon-Expandable Stent Causing Late Acquired Aneurysm Formation and Stent Malapposition

Chi Yuen Chan, MBChB; Eugene B. Wu, MD; Bryan P. Yan, MBBS

A 48-year-old man underwent elective percutaneous coronary intervention of a mid–left anterior descending (LAD) artery bifurcation lesion. A dedicated bifurcation self-expanding biolimus-eluting stent (3.0 × 14 mm AXXESS, Biosensors International, Morges, Switzerland) was implanted in the mid-LAD abutting the carina of the LAD and first diagonal (D1) bifurcation. Three balloon-expandable biolimus-eluting stents (Biomatrix, Biosensors) were placed proximal to the previous stent and in the distal main branch and the D1 side branch overlapping the AXXESS stent in a Y-configuration. High-pressure post-dilation of the proximal main vessel was performed with a 3.0-mm noncompliant balloon.

01 marzo 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Effect of the Endothelial Shear Stress Patterns on Neointimal Proliferation Following Drug-Eluting Bioresorbable Vascular Scaffold Implantation. An Optical Coherence Tomography Study

hristos V. Bourantas, MD, PhD∗; Michail I. Papafaklis, MD, PhD†; Anna Kotsia, MD‡; Vasim Farooq, MB, ChB∗; Takashi Muramatsu, MD, PhD∗; Josep Gomez-Lara, MD, PhD∗; Yao-Jun Zhang, MD, PhD∗; Javaid Iqbal, PhD∗; Fanis G. Kalatzis, MD, PhD§; Katerina K. Naka, MD, PhD‡; Dimitrios I. Fotiadis, PhD§; Cecile Dorange, MSc‖; Jin Wang, PhD¶; Richard Rapoza, PhD¶; Hector M. Garcia-Garcia, MD, PhD∗; Yoshinobu Onuma, MD∗; Lampros K. Michalis, MD‡; Patrick W. Serruys, MD, PhD∗

Objectives: This study sought to investigate the effect of endothelial shear stress (ESS) on neointimal formation following an Absorb bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) implantation.

01 marzo 2014

JACC: CARDIOVASCULAR INTERVENTIONS. Provisional Stenting of Coronary Bifurcations. Insights Into Final Kissing Balloon Post-Dilation and Stent Design by Computational Modeling

Peter Mortier, PhD∗; Yutaka Hikichi, MD‡; Nicolas Foin, PhD§; Gianluca De Santis, PhD∗; Patrick Segers, PhD†; Benedict Verhegghe, PhD∗; Matthieu De Beule, PhD∗

Objectives: This study sought to better understand and optimize provisional main vessel stenting with final kissing balloon dilation (FKBD).

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: Impact of age

Fabio Angeli MD1,*, Paolo Verdecchia MD2, Stefano Savonitto MD3, Nuccia Morici MD4, Stefano De Servi MD5 andClaudio Cavallini MD6

Background: It is unclear whether the benefits of an early invasive strategy (EIS) in patients with non-ST-segment elevation acute coronary syndromes (NSTEACS) equally apply to younger and older individuals. Elderly patients are generally less likely to undergo EIS when compared with younger patients.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Expandable sheath for transfemoral transcatheter aortic valve replacement: Procedural outcomes and complications

Bogdan Borz MD, Eric Durand MD, Phd, Christophe Tron MD, Matthieu Godin MD, Alexandre Canville MD, Camille Hauville MD, Alain Cribier MD andHélène Eltchaninoff MD*

Aims: It is currently unknown whether the expandable sheath (e-sheath) for transfemoral Edwards transcatheter aortic valve replacement (TAVR) has a lower rate of access complications than the 18/19F fixed size sheath (f-sheath). Our aim was to compare the incidence of procedural complications when using f-sheath vs. e-sheath during TAVR.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: An update

Alessandro Lupi MD1,*, Gioel Gabrio Secco MD2,3, Andrea Rognoni MD1, Maurizio Lazzero MD1, Rossella Fattori MD, PhD3, Imad Sheiban MD4, Angelo Sante Bongo MD1, Leonardo Bolognese MD5, Pierfrancesco Agostoni MD, PhD6 andItalo Porto MD PhD5

Objectives: To perform an updated meta-analysis comparing biodegradable polymer drug eluting stents (BP-DES) and durable polymer drug eluting stents (DP-DES).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.